Life Sciences 4.0: securing value through data-driven platforms

When the human body is the biggest data platform, who will capture value? 

In Life Sciences 4.0: securing value through platform-based businesses, EY’s latest edition of our Progressions series, we explore how health is being reimagined as a result of scientific and technological change and rising customer expectations.

We also examine the ramifications for life sciences companies’ market offerings, business models and the new capabilities needed as the disciplines of health care and technology merge to become “health technology.”

Direct to your inbox

Stay up to date with our Editor's picks newsletter. 

Subscribe